Visible light-induced singlet oxygen-mediated intracellular disassembly of polymeric micelles co-loaded with a photosensitizer and an anticancer drug for enhanced photodynamic therapy by Saravanakumar, G et al.
This journal is©The Royal Society of Chemistry 2015 Chem. Commun., 2015, 51, 9995--9998 | 9995
Cite this:Chem. Commun., 2015,
51, 9995
Visible light-induced singlet oxygen-mediated
intracellular disassembly of polymeric micelles
co-loaded with a photosensitizer and an
anticancer drug for enhanced photodynamic
therapy†
Gurusamy Saravanakumar, Junseok Lee, Jihoon Kim and Won Jong Kim*
Herein, we report a biocompatible amphiphilic block copolymer
micelle bearing a singlet oxygen-sensitive vinyldithioether cleavable
linker at the core–shell junction, which undergoes singlet oxygen-
mediated photocleavage in the presence of visible light. The micelle
facilitates the light-responsive release of singlet oxygen and an
anticancer drug for enhanced photodynamic therapy.
Photodynamic therapy (PDT) is emerging as a promising treat-
ment modality for several cancers and other non-malignant
diseases owing to its unique advantages such as non-invasiveness
and less systemic toxicity.1 This modality works by administering
a photosensitizer (PS) and then activating it with a light of
specific wavelength to generate reactive oxygen species, primarily
singlet oxygen (1O2), which induce apoptosis or necrosis of the
tumor cells. Despite its significant advantages, however, the
clinical potential of PDT is limited by factors such as poor
aqueous solubility of PSs and nonspecific accumulation of PSs
at the normal tissues. To surmount these issues, several nano-
carrier platforms such as liposomes,2 polymeric micelles,3
dendrimers,4 and self-assembled polymeric nanoparticles5 have
been investigated. Another important concern of PDT is the deple-
tion of ambient tumor oxygen through rapid and continuous
photochemical conversion of 3O2 to
1O2 at high fluence rates, which
can cause acute local hypoxic conditions and disrupt the photo-
dynamic process, thereby reducing the treatment eﬀectiveness.6
Integration of PDT with other treatment modalities such as
photothermal therapy7 or chemotherapy8 holds great promise
to circumvent the above critical limitation, because such a
combination therapy produces additive or synergistic therapeutic
eﬃcacy by targeting diﬀerent cellular or molecular pathways. It is
particularly gratifying to note that the results from recent pre-
clinical studies have also indicated that combining PDT with
chemotherapy can improve anticancer activity by overcoming
anticancer drug resistance9 which is a major impediment to
the success of chemotherapy. Considering highly liphophilic
and molecularly diverse characteristics of both PSs and anti-
cancer drugs, however, the development of smart and eﬃcient
carriers for the co-delivery of PSs and anticancer drugs is crucial
to realize the full potential of the combination therapy.
For such co-delivery, we envisioned that polymeric micelles
integrated with photo-responsive moieties could be a potential
carrier. Firstly, its core–shell structures could readily encapsu-
late multiple poorly water-soluble active agents into the hydro-
phobic core with high loading capacity. Secondly, without any
additional trigger mechanism, the co-loaded anticancer drugs can
be effectively released in the tumor cell to exert their therapeu-
tic effects because light is an integral part of the PDT process.
Although light-responsive micellar systems have been developed
by incorporating photochromic moieties such as azobenzene,10
2-diazo-1,2-napthoquinone,11 O-nitrobenzyl12 or coumarin13 into
their structure, unfortunately, most of them respond only to
the harmful UV light or multi-photon excitation that requires
enormously high laser power. Moreover, these systems are mostly
based on non-degradable polymeric compositions with limited
biocompatibility. Thus, there is an increasing need to develop
safe, low toxic and more efficient carrier systems that could
respond to the biomedically benign visible or near-infra-red
light. It should also be emphasized that, to date, no significant
effort has been made to the development of rationally designed
light-responsive carriers for dual-drug delivery.
In this study, we have designed and explored a novel bio-
compatible visible-light responsive amphiphilic poly(ethylene
glycol)-block-poly(caprolactone) copolymer (1O2-PEG-b-PCL) capable
of forming micelles by incorporating an 1O2-sensitive vinyl-
dithioether linker between the hydrophilic PEG and the hydro-
phobic and biodegradable PCL block. The double bond of the
vinyldithioether linker can readily react with 1O2 to form a
dioxetane intermediate, which is unstable and spontaneously
cleaved into fragments. Therefore, unlike other conventional
photo-responsive micelles that demand direct absorption of
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UV light, our micellar system exploits the 1O2 generated by
visible light during PDT as a trigger to disassemble the nano-
structure and release a co-loaded drug in the tumor cell for
eﬀective therapy (Scheme 1). Furthermore, the cleaved fragments
do not produce any toxic species like other photodegradable
moieties. The potential of the micelle as a dual-drug carrier for
enhanced photodynamic therapy was investigated by physical
co-encapsulation of a PS, chlorine e6 (Ce6), and a hydrophobic
anticancer drug, doxorubicin (DOX).
The synthetic strategy of a biocompatible 1O2-PEG-b-PCL
copolymer involves three steps (as illustrated in Fig. S1, ESI†).
First, a 1O2-sensitive vinyldithioether linker was synthesized
following a reported method,14 and its 1H-NMR spectrum (Fig. S2,
ESI†) was in good agreement with the literature. Second, a PEG
macroinitiator (1O2-PEG-OH) bearing an
1O2-sensitive linker
was synthesized by coupling a carboxylated PEG to the excess
of as-synthesized linker via Steglich esterification. The success-
ful conjugation was confirmed by the characteristic cis-alkene
peak (BSCHQCHSB) at d 6.12 ppm from the linker and the PEG
peaks (CH3–O– at d 3.36 ppm, and –CH2CH2– at d 3.62 ppm) in
the 1H-NMR spectrum of 1O2-PEG-OH (Fig. S3a, ESI†). Third,
the 1O2-PEG-b-PCL copolymer was synthesized by ring-opening
polymerization of the e-caprolactone (e-CL) monomer using the
1O2-PEG-OH as a macroinitiator in the presence of Sn(Oct)2 as a
catalyst. The chemical structure of the block copolymer was
confirmed by 1H-NMR spectroscopy (Fig. S3b, ESI†), in which all
the resonance peaks corresponding to the PEG and PCL segments
were observed. Further, the composition of the copolymer was
estimated by comparing the integration ratios of the peaks at
3.35 ppm from the methyl protons (CH3–) of PEG and the peak at
4.03 ppm from the methylene protons (–CH2–O–) of PCL seg-
ments. GPC analysis of the block copolymer showed a unimodal
molecular weight distribution (Fig. S4, ESI†). For comparison,
a control C-PEG-b-PCL copolymer of similar composition without
the linker was also synthesized. The compositions of these block
copolymers are summarized in Table S1 (ESI†).
Owing to its amphiphilicity, the 1O2-PEG-b-PCL copolymer
can form a self-assembled micellar structure (1O2-PM) under
aqueous conditions. The dynamic light scattering measure-
ments of micelles showed unimodal size distribution with an
average particle size of 40  3.1 nm and the TEM image
indicated that they have a spherical morphology (Fig. S5, ESI†).
Since the 1O2-PM is incorporated with a
1O2-sensitive linker,
first we investigated whether the 1O2-PEG-b-PCL copolymer can
undergo visible-light induced 1O2-mediated photocleavage. To
investigate the photocleavage, the 1H-HMR spectra of the block
copolymer solution containing 5 wt% Ce6 without and with
exposure to laser irradiation (30 mW cm2, 3 h) were recorded.
As shown in Fig. S6a (ESI†), the characteristic cis-alkene peak at
d 6.1 ppm of the linker completely disappeared, whereas all the
characteristic peaks of the polymers were observed without
laser irradiation. This result was further supported by the
GPC analysis (Fig. S6b, ESI†), which showed the appearance
of low molecular weight traces corresponding to the 1O2-PEG-
macroinitiator for the laser irradiated polymer. The above
results clearly indicate that the block copolymer fragments into
their two constituent blocks under laser irradiation.
After confirming the 1O2-mediated photocleavage of the
1O2-PEG-b-PCL copolymer, its potential as a carrier for co-delivery
of a PS and an anticancer drug was investigated by encapsulating
Ce6 and DOX via the dialysis method. For comparison, micelles
loaded with only Ce6 were also prepared using the same method.
The drug loading contents and loading eﬃciencies of these
micelles are summarized in Table S2 (ESI†). The size of Ce6 and
DOX co-loaded micelles (1O2-PM-Ce6-DOX, Fig. 1a) was higher
than Ce6-loaded micelles (1O2-PM-Ce6, Fig. S7a, ESI†), indicat-
ing that the co-loading of Ce6 and DOX in the hydrophobic core
increases the volume of micelles. The TEM images showed
spherical morphologies for both 1O2-PM-Ce6-DOX (Fig. 1b) and
1O2-PM-Ce6 (Fig. S7b, ESI†), although the size obtained by TEM
is smaller than the DLS measurement due to the non-hydrated
state. The size distributions of the micelles prepared using the
block polymer without the 1O2-linker are shown in Fig. S7c
(ESI†). To investigate whether 1O2-PM-Ce6-DOX micelles can be
disassembled by visible light, the TEM image of the micelles
was recorded after exposing them to laser light irradiation
(660 nm, 50mW cm2, 3 h). As expected, compared to the spherical
micelles before irradiation, highly degraded irregular aggregated
micelles were observed after laser irradiation (Fig. 1c). This clearly
indicates that light-induced 1O2-mediated photocleavage of the
linker could disrupt the micellar structures by disturbing the
hydrophilic–liphophilic balance. The UV-vis spectrum of
1O2-PM-Ce6 showed a similar characteristic Soret band and
Q-band absorption of free Ce6, indicating that the Ce6 in
Scheme 1 (a) Schematic illustration of (a) the formation of Ce6 and DOX
co-loaded micelles (1O2-PM-Ce6-DOX), (b) cellular uptake and visible light-
triggered 1O2-mediated intracellular co-delivery of Ce6 and DOX for combi-
nation chemo and photodynamic therapy; and (c) chemical structure of the
1O2-PEG-b-PCL copolymer.
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micelles existed in non-aggregated form (Fig. S8, ESI†). The
monomeric form is very important to ensure the photo-physical
characteristic of Ce6 for efficient 1O2 generation. The
1O2-
generation efficiency of 1O2-PM-Ce6-DOX was evaluated using
the N,N-dimethyl-4-nitrosoaniline (RNO)-histidine colorimetric
assay.15 In this assay, 1O2 generated from the photoexcited
sensitizer reacts with the imidazole moiety and forms a transient
complex that bleaches the RNO molecules. Thus, the amount of
1O2 can be directly correlated with a decrease in RNO absorbance
in the UV-vis spectrum. Fig. 1d shows the RNO concentration as a
function of time for free Ce6, 1O2-PM-Ce6-DOX and C-PM-Ce6-
DOX. Upon irradiation, free Ce6 showed a sharp decrease in
RNO concentration, indicating rapid 1O2 generation. Although
micelles showed a slow decrease in absorbance compared to the
free Ce6, 1O2-PM-Ce6-DOX showed a slightly fast decrease in RNO
concentration as compared to C-PM-Ce6-DOX. This increase in
1O2 generation efficiency of
1O2-PM-Ce6-DOX could be due to the
disassembly of micelles under laser irradiation, which releases
the Ce6 molecules in monomeric form. Next, the drug release
behaviour of the 1O2-PM-Ce6-DOX was investigated in PBS
(pH 7.4) with and without light. The cumulative release percent-
age of DOX loaded in micelles versus time is shown in Fig. 1e.
The DOX release rates were accelerated in the presence of light
irradiation compared to the dark conditions. The fast DOX
release from the micelles was most likely due to the degradation
micelles by the photocleavage of the vinyldithioether bonds. These
results suggest that micelles incorporated with a 1O2-sensitive
linker can effectively release co-loaded drugs under photodynamic
conditions at the target cells, which may improve the overall
therapeutic efficacy.
As designed, the light-responsive release of DOX from 1O2-PM-
Ce6-DOX was deemed to exhibit the spatio-temporal controlled
synergistic anticancer eﬀects. Therefore, the therapeutic potential
of 1O2-PM-Ce6-DOX was evaluated in vitro. Irrespective of light
on/oﬀ, the 1O2-PM and C-PM micelles demonstrated insignificant
cytotoxicity due to the biocompatibility of PEG and PCL (Fig. S9,
ESI†). In addition, no significant toxicity was observed with 1O2-
PM-Ce6 and C-PM-Ce6 micelles under dark conditions (Fig. 2a).
However, 1O2-PM-Ce6 and C-PM-Ce6 micelles showed slight cyto-
toxicity under light irradiation, which was ascribed to the cytotoxic
eﬀects of 1O2 generated from light-activated Ce6 (Fig. 2a). In the
cases of Ce6 and DOX loaded micelles under dark conditions, cell
viability was retained above 95% for micellar concentrations of up
to 5 mg mL1. The insignificant toxicity of DOX-releasing micelles
was due to the lower concentration of DOX compared with general
DOX doses16 for the in vitro test. Although each of 1O2 and DOX
released from the micelles could not exert the eﬀective cytotoxic
eﬀects on the cancer cells, the combinatorial use of them showed
the significant anticancer eﬃciency. Especially, under light irradia-
tion, the 1O2-PM-Ce6-DOXmicelle showed the most eﬃcient thera-
peutic eﬀects compared to the C-PM-Ce6-DOXmicelle (Fig. 2b). To
demonstrate the potential of the micelles for intracellular delivery,
cellular uptake and intracellular release behaviour of DOX from
the micelles were evaluated using confocal laser scan microscopy.
As shown in Fig. 3, the strongest fluorescence in the nucleus was
observed in the cells incubated with 1O2-PM-Ce6-DOX micelles
exposed to light compared to the dark conditions and control
micelles, which could be attributed to the enhanced release of
DOX by 1O2-responsive destruction of the micelle. Therefore,
it can be concluded that the 1O2-PM-Ce6-DOXmicelle showed the
potential not only for reducing the unintended cytotoxic eﬀects
Fig. 1 (a) DLS size distribution, and TEM images of 1O2-PM-Ce6-DOX
micelles (b) before and (c) after laser irradiation (scale bar is 200 nm). (d) 1O2
generation of 1O2-PM-Ce6-DOX micelles determined by RNO as a sensor.
(e) Visible light-triggered in vitro DOX release.
Fig. 2 Laser-induced cellular photo-toxicity of (a) 1O2-PM-Ce6 and C-PM-
Ce6 micelles, and (b) 1O2-PM-Ce6-DOX and C-PM-Ce6-DOX micelles in
PC3 cell lines.
Fig. 3 Intracellular visible light-triggered release of DOX from 1O2-PM-
Ce6-DOX micelles observed by CLSM using HeLa Cells. The micelles
without the vinyldithioether linker (C-PM-Ce6-DOX) were used as control.
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on the normal tissues during blood circulation, but also for
exhibiting the eﬀective anticancer eﬀects only on tumours.
In summary, visible light-triggered intracellular co-delivery
of an anticancer drug and a PS using biocompatible polymeric
micelles bearing vinyldithioether as a 1O2 cleavable linker is
realized for more eﬀective photodynamic therapy. Given the
high biocompatibility and ability to release drugs under photo-
dynamic therapy conditions, the micellar system developed in
this study could be a promising carrier for co-delivery of hydro-
phobic therapeutic drugs and PSs.
This work was supported by the Research Center Program of
IBS (Institute for Basic Science) in Korea (CA1203-02).
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